GGrantIndex
← Search

TARGETING TFE3 FUSION PROTEINS IN TRANSLOCATION RENAL CELL CARCINOMA (TRCC) BY PROTAC-MEDIATED TARGETED PROTEIN DEGRADATION

$121,937FY2022Defense Health AgencyDOD

The University Of Texas Southwestern Medical Center

Investigators

View source on USAspending →
TARGETING TFE3 FUSION PROTEINS IN TRANSLOCATION RENAL CELL CARCINOMA (TRCC) BY PROTAC-MEDIATED TARGETED PROTEIN DEGRADATION · GrantIndex